These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9324824)
61. Hormone therapy in postmenopausal and perimenopausal women. Magee SR; Taylor JS Am Fam Physician; 2006 Nov; 74(9):1501-3. PubMed ID: 17111886 [No Abstract] [Full Text] [Related]
62. Menopause and stroke and the effects of hormonal therapy. Lobo RA Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669 [TBL] [Abstract][Full Text] [Related]
63. [Coronary disease and hormonal treatment during the perimenopausal period]. Jedras M; Stawicki S; Mroczka T; Tomik Z; Stolarz P Pol Merkur Lekarski; 1998 Jan; 4(19):23-5. PubMed ID: 9553405 [TBL] [Abstract][Full Text] [Related]
64. Hormone replacement therapy is not a risk for venous thrombosis. Lip GY; Beevers M; Zarifis J; Beevers G Scott Med J; 1995 Feb; 40(1):30. PubMed ID: 7604241 [No Abstract] [Full Text] [Related]
65. Does estrogen replacement therapy predispose to thrombosis? Astedt B Acta Obstet Gynecol Scand Suppl; 1985; 130():71-4. PubMed ID: 3859978 [No Abstract] [Full Text] [Related]
66. Practical strategies for hormone replacement therapy and risk of venous thromboembolism. Greer IA Br J Obstet Gynaecol; 1998 Apr; 105(4):376-9. PubMed ID: 9609259 [No Abstract] [Full Text] [Related]
67. Postmenopausal female hormone use and venous thromboembolic disease in black women. Rosenberg L; Palmer JR; Adams-Campbell LL Am J Obstet Gynecol; 1997 Nov; 177(5):1275. PubMed ID: 9396935 [No Abstract] [Full Text] [Related]
68. Estrogen and the risk of coagulopathy. Lobo RA Am J Med; 1992 Mar; 92(3):283-5. PubMed ID: 1546727 [No Abstract] [Full Text] [Related]
69. Estrogen treatment. Int J Technol Assess Health Care; 1997; 13(3):488-91. PubMed ID: 9308283 [No Abstract] [Full Text] [Related]
70. Does estrogen-based therapy add to the risk of aesthetic surgery? Black DA; McCraw JB Plast Reconstr Surg; 2004 Apr; 113(4):1286-7. PubMed ID: 15083040 [No Abstract] [Full Text] [Related]
71. Estrogen replacement therapy and the risk of thromboembolism. Fischer J S D J Med; 1995 Jul; 48(7):213-4. PubMed ID: 7660102 [No Abstract] [Full Text] [Related]
72. Venous thromboembolism and estrogen-dance with the devil in thrombosis medicine. Vrotniakaite-Bajerciene K; Carrier M J Thromb Haemost; 2024 Aug; 22(8):2150-2152. PubMed ID: 39048267 [No Abstract] [Full Text] [Related]
73. [Tamoxifen and cardiovascular risk]. Farge D; Chanu B; Debourdeau P; Sauvaget F; Espie M; Gorins A; Rouffy J Ann Med Interne (Paris); 1994; 145(7):488-93. PubMed ID: 7864520 [No Abstract] [Full Text] [Related]
74. [Estrogen and thrombosis--additional research still needed]. Smith P Lakartidningen; 1995 Oct; 92(42):3869-70. PubMed ID: 7564644 [No Abstract] [Full Text] [Related]
75. [Postmenopausal hormonal substitution and risk of venous thromboembolism. Need for prospective, randomized trials]. Arnesen H; Qvigstad E Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4064. PubMed ID: 9441436 [No Abstract] [Full Text] [Related]
76. [Risk of venous thromboembolism during postmenopausal hormone therapy]. Pedersen AT; Ottesen B Ugeskr Laeger; 1996 Nov; 158(48):6923-4. PubMed ID: 8984757 [No Abstract] [Full Text] [Related]
77. [Estrogens and cardiovascular diseases: should current guidelines be changed?]. Beller F; Theiss W Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812 [TBL] [Abstract][Full Text] [Related]
78. [Postmenopausal hormone therapy and venous thrombosis]. Høibraaten E Tidsskr Nor Laegeforen; 1996 Feb; 116(5):653. PubMed ID: 8658462 [No Abstract] [Full Text] [Related]
79. [Risk of venous thrombosis during postmenopausal estrogen therapy? The reporting system of adverse effects is functioning]. Buajordet I; Dybwad TB Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2644-5. PubMed ID: 9324824 [No Abstract] [Full Text] [Related]